Try our beta test site

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: November 10, 2010
Last updated: March 14, 2014
Last verified: March 2014